MSN’s ANDA for cancer drug opposed by Exelixis in US patent infringement suit
MLex Summary: Exelixis filed a patent infringement suit against Indian generic manufacturer MSN in the US District of Delaware, accusing the company of patent infringement over its Abbreviated New Drug Application...To view the full article, register now.
Already a subscriber? Click here to view full article